Bone graft systems are used to promote new bone growth in patients undergoing neck and spinal surgeries. One popular option for doctors is the Medtronic Infuse bone graft system initially approved by the FDA in 2002. Since then, it’s been used to treat more than 50,000 patients. However, the product is being reevaluated due to increased risks of severe side effects and health complications after use in a surgical procedure.
Common injuries sustained from the use of the Medtronic Infuse bone graft system include:
- compression of the airway and/or neurological structures in the neck
- difficulty swallowing, breathing, or speaking
- infection at the surgical site
- irregular bone growth
- nerve pain or damage
- swollen neck and throat tissue
Due to these increased risks, the FDA has issued a public health notification that states that patients may experience complications between 2 and 14 days following their procedure. These complications can require immediate medical attention and/or corrective surgeries.
If you or someone you love suffered complications after a surgical procedure involving the use of the Medtronic Infuse bone graft system, you may be entitled to significant compensation from the manufacturer. Call our experienced drug injury lawyers today for a free evaluation of your claim.